# VIR ETFs: 69 Funds That Hold Vir Biotechnology Inc

> 69 thematic and core ETFs hold Vir Biotechnology Inc (VIR). IDNA holds the most, at 1.30% of the fund on Nov 3, 2026. Weights and dates for every holder.

Data as of Nov 5, 2026. Rebuilt every trading night.

## ETFs that hold Vir Biotechnology Inc

69 thematic and core ETFs hold Vir Biotechnology Inc , by holdings dated Jun 30, 2026 to Nov 3, 2026 . IDNA holds the most, at 1.30% of the fund on Nov 3, 2026 . The next largest are GNOM (0.98%) and PSCH (0.72%).

1 income and other fund on it is listed below.

### Thematic and core funds that hold it

| Fund | Name | Share of the fund | Holdings filed | Asset |
| --- | --- | --- | --- | --- |
| IDNA | iShares Genomics Immunology and Healthcare ETF | 1.30% | Nov 3, 2026 | Equity |
| GNOM | Global X Genomics & Biotechnology ETF | 0.98% | Aug 31, 2026 | Equity |
| PSCH | Invesco S&P SmallCap Health Care ETF | 0.72% | Nov 3, 2026 | Equity |
| BBC | Virtus Biotech Clinical Trials ETF | 0.67% | Jul 31, 2026 | Equity |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.65% | Nov 3, 2026 | Equity |
| NIXT | Research Affiliates Deletions ETF | 0.46% | Jun 30, 2026 | Equity |
| FYX | First Trust Small Cap Core AlphaDEX Fund | 0.31% | Nov 3, 2026 | Equity |
| XBI | State Street SPDR S&P Biotech ETF | 0.28% | Nov 3, 2026 | Equity |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.20% | Nov 3, 2026 | Equity |
| JMEE | JPMorgan Small & Mid Cap Enhanced Equity ETF | 0.17% | Nov 3, 2026 | Equity |
| WCEO | Hypatia Women CEO ETF | 0.17% | Jul 31, 2026 | Equity |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.13% | Nov 3, 2026 | Equity |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.12% | Nov 3, 2026 | Equity |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.12% | Nov 3, 2026 | Equity |
| AVSC | Avantis U.S. Small Cap Equity ETF | 0.11% | Nov 2, 2026 | Equity |
| IWN | iShares Russell 2000 Value ETF | 0.10% | Nov 3, 2026 | Equity |
| VTWV | Vanguard Russell 2000 Value ETF | 0.10% | Sep 30, 2026 | Equity |
| FSEV | Fidelity Enhanced Small Cap Value ETF | 0.10% | Jun 30, 2026 | Equity |
| IBB | iShares Biotechnology ETF | 0.10% | Nov 3, 2026 | Equity |
| VIOV | Vanguard S&P Small-Cap 600 Value ETF | 0.09% | Sep 30, 2026 | Equity |
| SLYV | State Street SPDR S & P 600 Small Cap Value ETF | 0.09% | Nov 3, 2026 | Equity |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.09% | Nov 3, 2026 | Equity |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.09% | Nov 3, 2026 | Equity |
| IJS | iShares S&P Small-Cap 600 Value ETF | 0.09% | Nov 3, 2026 | Equity |
| QVMS | Invesco S&P SmallCap 600 QVM Multi-factor ETF | 0.09% | Nov 3, 2026 | Equity |
| PWS | Pacer WealthShield ETF | 0.08% | Jul 31, 2026 | Equity |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.08% | Sep 30, 2026 | Equity |
| VIOO | Vanguard S&P Small-Cap 600 ETF | 0.08% | Sep 30, 2026 | Equity |
| IJR | iShares Core S&P Small-Cap ETF | 0.08% | Nov 3, 2026 | Equity |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 0.08% | Nov 3, 2026 | Equity |
| FESM | Fidelity Enhanced Small Cap Core ETF | 0.07% | Jun 30, 2026 | Equity |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 0.07% | Sep 30, 2026 | Equity |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.07% | Nov 3, 2026 | Equity |
| SLYG | State Street SPDR S & P 600 Small Cap Growth ETF | 0.07% | Nov 3, 2026 | Equity |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.06% | Jul 31, 2026 | Equity |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.06% | Jul 31, 2026 | Equity |
| IWM | iShares Russell 2000 ETF | 0.05% | Nov 3, 2026 | Equity |
| VTWO | Vanguard Russell 2000 ETF | 0.05% | Sep 30, 2026 | Equity |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | 0.05% | Sep 30, 2026 | Equity |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.04% | Jun 30, 2026 | Equity |
| RSSL | Global X Russell 2000 ETF | 0.03% | Jul 31, 2026 | Equity |
| TECB | iShares U.S. Tech Breakthrough Multisector ETF | 0.03% | Nov 3, 2026 | Equity |
| DFAS | U.S. Small Cap Portfolio: ETF Class Shares | 0.03% | Jul 31, 2026 | Equity |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% | Aug 31, 2026 | Equity |
| MSML | iShares MSCI USA Small-Cap ETF | 0.02% | Nov 3, 2026 | Equity |
| ISCV | iShares Morningstar Small-Cap Value ETF | 0.02% | Nov 3, 2026 | Equity |
| VB | Vanguard Morningstar Small-Cap ETF | 0.02% | Sep 30, 2026 | Equity |
| VHT | Vanguard Health Care ETF | 0.02% | Sep 30, 2026 | Equity |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.02% | Nov 3, 2026 | Equity |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.02% | Nov 3, 2026 | Equity |
| WSML | iShares MSCI World Small-Cap ETF | 0.02% | Nov 3, 2026 | Equity |
| VXF | Vanguard Extended Market ETF | 0.02% | Sep 30, 2026 | Equity |
| ISCB | | 0.02% | Jul 31, 2026 | Equity |
| FHLC | Fidelity MSCI Health Care Index ETF | 0.01% | Jul 31, 2026 | Equity |
| SMDX | Intech S&P Small-Mid Cap Diversified Alpha ETF | 0.01% | Jul 31, 2026 | Equity |
| DXUV | US Vector Equity Portfolio ETF Class Shares | 0.01% | Jul 31, 2026 | Equity |
| ONEQ | Fidelity Nasdaq Composite Index ETF | 0.01% | Aug 31, 2026 | Equity |
| VLU | State Street SPDR S&P 1500 Value Tilt ETF | 0.01% | Nov 3, 2026 | Equity |
| DFAC | U.S. Core Equity 2 Portfolio ETF Class Shares | Vir Biotechnology Inc (ticker VIR, listed in US) is matched in every holdings book ETFIQ publishes, by its ticker and name. A share of the fund is the weight its issuer published, as of the Holdings filed date. Shares, preferred shares and debt are told by each fund’s N-PORT asset type. A fund holding only the company’s debt or preferred shares is listed under them, not counted as holding its shares. Options, swaps, futures and cash do not count as holding a company: a call option on a share is not the share. Funds whose book is gross exposure, not a portfolio, are left out.

Each row shows the date the fund last filed.

Look up another company .

### Questions people ask

Which ETFs hold Vir Biotechnology Inc? 69 thematic and core ETFs hold Vir Biotechnology Inc, by holdings dated Jun 30, 2026 to Nov 3, 2026. The largest positions are IDNA at 1.30% of the fund on Nov 3, 2026, GNOM at 0.98% of the fund on Aug 31, 2026 and PSCH at 0.72% of the fund on Nov 3, 2026. 1 income and other fund on it is listed apart.

---

Source: ETFIQ, independent ETF data. Recomputed nightly from public filings and prices.
Cite: ETFIQ, ETFs holding Vir Biotechnology Inc, data as of Nov 5, 2026. https://etfiq.com/holdings/vir/
Licence: https://etfiq.com/license/ Data ETFIQ computes is free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.
HTML: https://etfiq.com/holdings/vir/